A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

October 27, 2018

Primary Completion Date

August 19, 2022

Study Completion Date

August 19, 2022

Conditions
Atopic Dermatitis
Interventions
DRUG

Upadacitinib

Upadacitinib is administered orally.

DRUG

Placebo for upadacitinib

Placebo is administered orally.

DRUG

Topical Corticosteroids (TCS)

It is administered concomitantly with upadacitinib or placebo.

Trial Locations (43)

1430023

Tampopo Dermatology Clinic /ID# 207013, Ōta-ku

1900023

Tachikawa Dermatology Clinic /ID# 206996, Tachikawa-shi

8190167

Matsuda Tomoko Dermatological Clinic /ID# 206288, Fukuoka

491-8558

Ichinomiya Municipal Hospital /ID# 205942, Ichinomiya-shi

464-0821

Central Clinic /ID# 206558, Nagoya

467-8602

Nagoya City University Hospital /ID# 207566, Nagoya

818-0083

Yasumoto Dermatology Clinic /ID# 206480, Chikushino-shi

813-0044

Kiryu Dermatology Clinic /ID# 206044, Fukuoka

819-0373

Medical Corporation Matsuo Clinic /ID# 207323, Fukuoka

816-0802

Higuchi Dermatology Urology Clinic /ID# 206287, Kasuga-shi

505-8510

Central Japan International Medical Center /ID# 205684, Minokamo-shi

376-0024

Kiryu Kosei General Hospital /ID# 206155, Kiryu-shi

371-8511

Gunma University Hospital /ID# 207016, Maebashi

721-8511

Fukuyama City Hospital /ID# 206761, Fukuyama-shi

078-8510

Asahikawa Medical University Hospital /ID# 206521, Asahikawa-shi

003-0026

Medical Corporation Kato Dermatology Clinic /ID# 206561, Sapporo

003-0833

Kitago Dermatology Clinic /ID# 207025, Sapporo

060-0033

Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 206519, Sapporo

660-8511

Kansai Rosai Hospital /ID# 205918, Amagasaki-shi

660-8550

Hyogo Prefectural Amagasaki General Medical Center /ID# 206974, Amagasaki-shi

650-0017

Kobe University Hospital /ID# 206200, Kobe

259-1193

Tokai University Hospital /ID# 206657, Isehara-shi

211-0063

Medical corporation Kojunkai Kosugi Dermatology Clinic /ID# 206766, Kawasaki-shi

211-8533

Nippon Medical School Musashi Kosugi Hospital /ID# 206656, Kawasaki-shi

222-0036

Yokohama Rosai Hospital /ID# 206648, Yokohama

862-0950

Suizenji Dermatology Clinic /ID# 205871, Kumamoto

852-8501

Nagasaki University Hospital /ID# 206118, Nagasaki

940-2085

Nagaoka Red Cross Hospital /ID# 209817, Nagaoka-shi

574-0046

Isonokami dermatological clinic /ID# 206923, Daito-shi

572-0838

Medical corporation Kojinkai Yoshioka Dermatology Clinic /ID# 209704, Neyagawa

420-8527

Shizuoka General Hospital /ID# 207122, Shizuoka

120-0034

Mildix Skin Clinic /ID# 206829, Adachi-ku

103-0028

Yaesu Nihonbashi Skin Clinic /ID# 207125, Chuo-ku

103-0031

Fukuwa clinic /ID# 206760, Chuo-ku

104-0031

Hosono Clinic /ID# 205953, Chuo-ku

173-8610

Nihon University Itabashi Hospital /ID# 206186, Itabashi-ku

108-0014

Mita Dermatology /ID# 206694, Minato-ku

164-0001

Medical Corporation Jitai-kai Nakano Dermatology Clinic /ID# 206882, Nakano-ku

165-0026

Matsuyama Dermatology /ID# 205998, Nakano-ku

114-0052

Miu Skin Clinic /ID# 206911, Ōta-ku

143-0013

Tokyo Rosai Hospital /ID# 205809, Ōta-ku

158-0097

Naoko Dermatology Clinic /ID# 205334, Setagaya-ku

930-8550

Toyama Prefectural Central Hospital /ID# 206286, Toyama

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY